New FDA-approved screening options make colorectal cancer detection easier than ever, with 91% survival rates when caught ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

Women are twice as likely to be affected by dementia ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative AI-based cardiovascular risk ...

The wearable maker is launching a new panel focused on women's health through its Whoop Labs blood testing service. It's also adding a new feature to its app that surfaces information about hormonal ...

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing cognitive problems and dementia.

The news comes one week after Boston-based Whoop announced broader plans to expand the business, including by increasing its staff by as much as 75 percent this year.